Enhancing Drug Production: Centers of Excellence for Secure Medicine Supply
This act aims to improve the security of drug supply in the United States by supporting modern pharmaceutical manufacturing methods. This will make medicines more accessible and of higher quality, directly impacting citizens' health and safety. The creation of specialized research centers is intended to foster innovation and train future professionals in this field.
Key points
Establishes "National Centers of Excellence" in advanced and continuous pharmaceutical manufacturing to conduct research and development.
These centers will collaborate with drug manufacturers and government agencies to implement new technologies and train the workforce.
The goal is to reduce reliance on foreign suppliers and enable faster responses to drug shortages or health threats like pandemics.
Funding of $80 million is authorized for fiscal years 2022-2026 to support these centers.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.